Envestnet Asset Management’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
122,790
+43,611
+55% +$688K ﹤0.01% 3415
2025
Q4
$1.44M Sell
79,179
-36,080
-31% -$608K ﹤0.01% 3061
2025
Q3
$1.69M Sell
115,259
-27,970
-20% -$479K ﹤0.01% 2994
2025
Q2
$2.61M Buy
143,229
+74,543
+109% +$1.52M ﹤0.01% 2645
2025
Q1
$1.36M Buy
68,686
+8,682
+14% +$150K ﹤0.01% 2984
2024
Q4
$1.03M Buy
60,004
+24,293
+68% +$457K ﹤0.01% 3155
2024
Q3
$714K Buy
35,711
+22,595
+172% +$351K ﹤0.01% 3313
2024
Q2
$147K Buy
13,116
+1,929
+17% +$16.2K ﹤0.01% 4003
2024
Q1
$73.8K Buy
+11,187
New +$61.1K ﹤0.01% 4085
2023
Q4
Sell
-22,245
Closed -$79.6K 4045
2023
Q3
$79.6K Buy
22,245
+4,814
+28% +$18.5K ﹤0.01% 3899
2023
Q2
$64.3K Buy
17,431
+6,989
+67% +$25.9K ﹤0.01% 3860
2023
Q1
$34.6K Buy
+10,442
New +$36.1K ﹤0.01% 3890

Other funds holding ADMA